Resultado da Busca
Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is executive chairman and former CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America).
- Executive chairman, Merck & Co.
12 de jun. de 2023 · Listen to former Merck CEO Ken Frazier share his insights on how he led the company through challenges and opportunities, how he ensured that science stayed at the core of Merck's mission, and how he sees business's role in society. He also discusses his humble roots, his vision for Merck, and his views on R&D investments.
4 de fev. de 2021 · KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021.
4 de fev. de 2021 · Merck & Co's chief executive Kenneth Frazier is retiring at the end of June, the drugs company said. The firm said he would be replaced by current chief financial officer Robert Davis, who...
4 de fev. de 2021 · Frazier, who challenged Trump on race issues, will be replaced by CFO Robert Davis. He is one of the few Black corporate leaders in the US and led Merck for a decade.
4 de fev. de 2021 · Merck CEO Kenneth Frazier, who is currently one of the few Black CEOs of a Fortune 500 company, is retiring in June, ending a nearly 30-year run with the company.
27 de out. de 2021 · Learn how Ken Frazier, the former CEO of Merck, was selected by Chief Executive magazine as the 2021 CEO of the Year for his transformational leadership and social impact. Read his inspiring story, his vision for research and his role in racial equality and COVID-19 response.
